Profile
Dr. Richard Auburn is on the Board of Directors at Singula Bio Ltd.
Dr. Auburn was previously employed as a Principal Licensing & Ventures Manager by Oxford University Innovation Ltd.
He received his undergraduate degree from the University of Aberdeen and a graduate degree from the University of Cambridge.
Richard Auburn active positions
| Companies | Position | Start |
|---|---|---|
Singula Bio Ltd.
Singula Bio Ltd. BiotechnologyHealth Technology Develops novel neoantigen-based cell therapies for cancer | Director/Board Member | 01/11/2020 |
Former positions of Richard Auburn
| Companies | Position | End |
|---|---|---|
Oxford University Innovation Ltd.
Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements. | Private Equity Investor | 01/06/2024 |
Training of Richard Auburn
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Aberdeen
University of Aberdeen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oxford University Innovation Ltd.
Oxford University Innovation Ltd. Investment ManagersFinance Oxford University Innovation invests in spun out companies located in the United Kingdom. The firm targets companies operating in the fields of across a broad range of sectors and industries. It provides financing for seed and early-stage capital requirements. | Finance |
Singula Bio Ltd.
Singula Bio Ltd. BiotechnologyHealth Technology Develops novel neoantigen-based cell therapies for cancer | Health Technology |
- Stock Market
- Insiders
- Richard Auburn
















